title: Association between vitamin D receptor gene polymorphisms and tubular citrate handling in calcium nephrolithiasis.
abstract: OBJECTIVE
  Hypocitraturia is a risk factor for calcium nephrolithiasis. 1,25(OH)2D3 influences renal citrate handling and enhances citraturia. The aim of this study was to evaluate the relationship between vitamin D receptor (VDR) allelic variant and urinary citrate excretion in recurrent stone formers (SF) patients.
  
  
  METHODS
  Case-control study.
  
  
  METHODS
  A total of 220 recurrent calcium oxalate SF patients and 114 healthy control (C) subjects were enrolled for this study. Subjects with urinary tract infections, hyperparathyroidism, cystinuria >70 micromol/24 h, gouty diathesis, renal tubular acidosis, renal failure, chronic diarrhoeal states, intake of thiazide diuretics, angiotensin-converting enzyme (ACE)-inhibitors, glucocorticoids or oestrogens were excluded. A standard constant diet was given for 7 days. The 24-h urinary citrate excretion and the active tubular reabsorption of filtered citrate (Rcit) were evaluated. Hypocitraturia was defined as a urinary citrate excretion lower than 1.7 mmol day-1. Stone formers patients and C were genotyped for BsmI and TaqI VDR alleles. Contingency table chi-square tests were used to compare genotype frequencies in hypocitraturic SF patients, normocitraturic SF and C.
  
  
  RESULTS
  The prevalence of hypocitraturia in SF patients was 32.7% (72 of 200). Hypocitraturia in these patients resulted from excessive Rcit of a normal load of citrate. We found a different distribution (P < 0.05) of BsmI and TaqI VDR genotypes in hypocitraturic SF patients compared with normocitraturic SF and C. In particular, the prevalence of bb and TT VDR genotypes in hypocitraturic SF was significantly higher than in normocitraturic SF and C.
  
  
  CONCLUSIONS
  These results point to a genetic association between BsmI and TaqI VDR polymorphisms and idiopathic hypocitraturia in calcium-oxalate recurrent SF patients.
authors.affiliation: Department of Clinical and Experimental Medicine, Federico II University Medical School, via S. Pansini 5, 80131 Naples, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Mossetti
authors.forename: P
authors.initials: P
authors.lastname: Vuotto
authors.forename: D
authors.initials: D
authors.lastname: Rendina
authors.forename: F G
authors.initials: FG
authors.lastname: Numis
authors.forename: R
authors.initials: R
authors.lastname: Viceconti
authors.forename: F
authors.initials: F
authors.lastname: Giordano
authors.forename: M
authors.initials: M
authors.lastname: Cioffi
authors.forename: F
authors.initials: F
authors.lastname: Scopacasa
authors.forename: V
authors.initials: V
authors.lastname: Nunziata
mesh_terms: D000328:Adult; D002129:Calcium Oxalate / Q000378:metabolism*; D016022:Case-Control Studies; D019343:Citric Acid / Q000652:urine*; D005260:Female; D005838:Genotype; D006801:Humans; D007669:Kidney Calculi / Q000235:genetics* / Q000378:metabolism / Q000652:urine; D007684:Kidney Tubules / Q000378:metabolism; D008297:Male; D011110:Polymorphism, Genetic; D018167:Receptors, Calcitriol / Q000235:genetics*; D012008:Recurrence
chemical_list: D018167:Receptors, Calcitriol; D002129:Calcium Oxalate; D019343:Citric Acid